Amber Scorah | 03/09/2011
Amorphous spray dried dispersions (SDDs) have emerged as a broadly applicable technology for the delivery of poorly soluble drug molecules. Methods for formulating and predicting the physical stability of these formulations are becoming better understood and more widespread. However, there are practical aspects of final dose formulation and characterisation that are critical to attaining the full performance advantages offered by SDD formulations. Today, Dr. Corey Bloom, Directory of Formu...
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More